Healthix Inc.

“Healthix, inc. Uses adp totalsource, a professional employer organization ("peo"). As a professional employer organization, totalsource provides professional employer services to healthix, inc. In the peo relationship totalsource and healthix, inc. Share certain responsibilities and allocate other employer responsibilities between each other. Healthix, inc. Remains an employer of the worksite employees and totalsource is a co-employer of healthix, inc.'s employees. Healthix, inc. Has: direction and control over employees as is necessary to conduct its business, discharge and fiduciary responsibility it may have, or comply with any applicable licensure, regulatory or statutory requirement of healthix, inc. Control over the day to day job duties of employees and over the job sites at which, or from which employees perform services responsibility over the professional and licensed activities of employees including ensuring that employees are supervised by licensed individuals as required by law and for determining whether an applicant or employee meets healthix, inc.'s hiring criteria and is qualified to safely and completely perform his or her job totalsource reserves a right of direction and control over employees as is necessary to fulfill its obligations and provide its services under an agreement between healthix, inc. And totalsource. Totalsource and healthix, inc. Have a right to hire, discipline, and terminate employees as to each one's employment relationship with employees. The peo was paid $115,512 during 2019 for services provided.”

“Membership: in order for an organization or individual to qualify to be a participant in the regional health information organization ("rhio") operated by the corporation ("participant"), he/she or it must enter into a rhio services, participation or similar agreement with the corporation (each, a "rhio services agreement"), the form of which has been approved by the board of directors of the corporation ("board"), to participate in a clinical information data exchange program with the corporation and to act as a data source and/or data user with respect to the corporation's data exchange. A participant's participation in the corporation will terminate if the rhio services agreement is terminated for any reason.”

“After the form is prepared by outside accountants, it will first be reviewed by the svp & cfo. If there are any suggested changes or modifications, he will communicate directly with the outside accountants. Once the svp & cfo is satisfied with the 990, he will pass it on to the ceo for his review. Once the ceo is satisfied with the 990, the next step is to pass it on to the chairman of the finance committee, who is a member of the executive committee and the board of directors, for his review. Once this individual is satisfied with the 990, it will be passed on to the full executive committee. This committee is a subset of the full healthix, inc. Board and is charged with making many key decisions affecting the company. It is this group of individuals that will authorize the filing of the 990. Once the executive committee is satisfied with the 990 and has authorized its filing, the svp & cfo will provide an electronic copy to the full board of directors prior to the extended due date of the return. The board will be informed that the executive committee has reviewed and approved the 990. If any board member has any questions or concerns they will be instructed to contact the svp & cfo, who will resolve their inquiries promptly.”

“All directors, officers, and key persons will, at least annually thereafter, file a written conflict of interest disclosure statement with healthix senior director of compliance. Healthix senior director of compliance will provide copies of all completed statements to the chair of the audit and compliance committee of the board for review. New director must file conflict of interest prior to being elected to become a healthix board member. For directors, the conflict of interest disclosure statement will specifically include, among other disclosable conflicts of interest, a statement identifying, to the best of the director's knowledge, any entity of which he or she is an officer, director, trustee, member, owner (either as a sole proprietor or a partner), or employee and with which healthix has a relationship, and any transaction in which healthix is a participant and in which the director might have a disclosable conflict of interest. All completed conflict of interest disclosure statements that raise an actual or potential conflict of interest, or that create the appearance of an actual or potential conflict of interest, will be forwarded by the chair of the audit and compliance committee to the audit and compliance committee for their consideration. The audit and compliance committee of the board will conduct a full review of all matters (e.g., contracts, transactions or arrangements) for which an actual or potential conflict of interest or the appearance of an actual or potential conflict of interest has been identified. In so doing, the audit and compliance committee of the board will: a. Consider all relevant facts and circumstances involved in the matter, and in particular, what is fair, reasonable and in the best interests of healthix; b. Exclude the affected individual(s) from being present at or participating in, or being counted in the quorum for, the deliberations or voting on the matter; c. Prohibit the affected individual(s) from any attempt to influence improperly the deliberations or voting on the matter; d. Permit the affected individual(s), upon request of the audit and compliance committee of the board, to present information concerning the matter at a meeting prior to commencement of deliberations or voting on the matter. E. Not permit any director to vote or be counted in determining the quorum for any vote, on any transaction between healthix and another corporation, firm, association or other entity in which the director is an officer or director or has a direct or indirect substantial financial interest. The audit and compliance committee of the board will make a final and binding determination as to whether a conflict of interest exists or may exist on any matter in which there is a disclosable conflict of interest, and what course healthix will take in connection with the matter. The audit and compliance committee of the board will contemporaneously document in writing in appropriate minutes of any meeting at which the matter is deliberated or voted upon all deliberations and determinations relating thereto, including, at a minimum: 1. The names and positions of persons who disclosed that they were related parties or otherwise were found to be related parties or to have a conflict of interest, a description of the nature of the relationship and/or substantial financial interest which gave rise to such disclosure or identification, and a description of the contract, transaction or arrangement at issue; 2. The names of the audit and compliance committee who were present during the taking of the action to determine whether a conflict of interests was present, and the basis for there being a quorum for the taking of such action without including any related parties or affected parties; 3. The steps taken by the audit and compliance committee members of the board to determine whether a conflict of interest was present; 4. The audit and compliance committee board member's decision as to whether a conflict”

“For salary adjustments made in 2019, there was no change in the process from previous years. The organization last used a compensation consultant in 2015, and plans to refresh the compensation study in 2020. The same process was used in 2019 as in 2018 for determining bonuses--no changes. Ceo comp is set by employment agreement/offer letter to current ceo, who took over on may 1, 2019 due to retirement of the previous ceo. Goals were set for all employees at the beginning of 2019, and their performance was measured against goals after 2019 concluded. Bonuses which were accrued at 12/31/18 (based on 2018 performance) were paid in 2019, and those which were accrued at 12/31/19 (based on 2019 performance) were paid out in 2020. The incentive compensation (i.e. Bonus) programs were approved by the executive committee for both 2018 & 2019, and were also distributed to all employees. The by-laws create a committee of the board with full powers of the board to review and approve the compensation of officers and other key employees. The committee, which is healthix's executive committee, consists of trustees who have no connection to healthix except as trustees and they have no conflicts as to matters they consider. The committee meets several times a year as needed and always reviews and determines officer and key employee compensation. For purposes of their review the committee considers the recommendations of the ceo for all persons other than the ceo. This process was last undertaken in 2019. The board's approval for the compensation of officers and other key employees is documented via email.”

“The organization makes its form 990 and form 1023 available for public inspection as required under section 6104 of the internal revenue code. It is posted on guidestar.org and other similar types of websites. In addition, the financial statements, conflict of interest policy, articles of incorporation and by-laws are also available upon written request or by calling the organization directly.”

“The high gap closure (hgc) hub grant initiative allowed healthix to build upon the success of the healthix hub model program by partnering with new ehrs and establishing hub model connections as additional avenues to facilitate participation with providers not connected to a qe. Adding a total of 6 additional hub ehrs allowed healthix to reduce the barriers to access for providers who otherwise could not connect to the qe in an efficient cost-effective manner. Healthix has had great success over the past 3 years connecting more than 500 sites through a hub model ehr, but there remain many ambulatory providers in the healthix service area of new york city and long island, who are not yet participating in any qe in the shin-ny. The hgc hub model grant enabled healthix to continue upon that success and further close the gap in qe participation. In the hub model, the ehr vendor maintains one interface to healthix from its data center or interface engine, which support multiple clients; and the vendor can easily add the participant to the vendor's existing interface with healthix. The grant project had three phases: 1) identify candidate ehrs in the market place, based on lists provided by acos and ipas who were identified as capable of building a hub model connection. Complete analysis, scoping and planning with the identified ehrs; 2) develop up to 6 new hub model interfaces with ambulatory ehrs; 3) go-live with and pilot at least one practice for each new hub created. At grant completion, healthix was able to complete all 6 hub ehr builds and go live with at least one pilot site. Description of outcomes phase 1: hub-model vetting process the goal for the first phase of the grant was to identify target ehr vendors and distinguish the volume of clients in the healthix market place. Healthix then assessed their readiness and willingness to establish a hub connection with the qe which is confirmed through a technical scope sign-off. Healthix completed this vetting process with over 21 different ehrs and identified 6 ambulatory ehrs that were technically capable of participating in the healthix hub-model initiative and going live by grant deadline. The ehrs were antworks, azalea, criterions, greenway-intergy, medi-ehr, and suncoast for totalmd. Once the projects kicked off in phase 2 it was evident that suncoast for totalmd did not have the technical capabilities originally agreed upon in the technical scope sign-off. Healthix with the approval of the new york ehealth collaborative (nyec) was able to identify a 7th ehr celerity - that would be able to meet the grant deliverables. Celerity replaced suncoast as the 6th ehr projected to go live. Phase 2 and 3: develop new hub interfaces with up to 6 ehrs and pilot with at least one practice for each new hub created. With the final 6 ehrs identified (antworks, azalea, criterions, greenway-intergy, medi-ehr, and celerity) and technical scopes signed off on, kick-off was scheduled with all 6 ehrs within the 2018 calendar year. Each interface was comprised of a patient registration feed (either through adt hl7 message or pix ihe transaction) and a clinical data feed (ccda). Consent as capable by the ehr was provided in the adt feed or through a xacml document. One ehr, greenway-intergy, did not have the capability of creating a consent user interface and was scoped to utilize healthix hosted registration for their customers connecting to healthix. All final 6 ehrs identified completed successful testing and onboarding for at least one pilot site. This final phase consisted of data validation for patient registration and clinical data flow of common clinical data and a data monitoring process prior to conducting participant user acceptance testing, which demonstrates the ehr functionality through the hub for the pilot site. Criterions exceeded this expectation and post go live completed an additional 12 integrations. Description of processes in collaboration among healthix business and techn”

“The following two technical communication methods were used for clinical data transfer in the high gap closure project: webservice or secure file transfer protocol (sftp) 1) for new participants connecting to healthix through the new hub with their ehr vendor, their clinical data was sent to healthix as a ccd/c-cda via web services to the healthix bus and data then stored on the hub and edge servers. An alternate option used by some ehrs was to use secure file transfer protocol (sftp), clinical data was sent to healthix as a ccd/c-cda via sftp and stored on the hub and edge servers. 2) upon query, clinical data was fetched from healthix and returned to the participant also through web services. Clinical data can be queried either through the portal or the participant's ehr. 3) when a patient record is queried, healthix identifies the patient being searched using the verato mpi, the hub then determines all the records associated with the patient and pulls the relevant records from the various edge servers. The results are returned to the access gateway to be delivered to the participant. 4) most participants choose to subscribe to clinical event notifications. The cen gateway manages the detection of events, composing the messages and sending them to the subscriber through the gateway over a vpn tunnel to the subscriber as an hl7 mdm message. Cens delivered to subscribers via the clinical message center are sent through the access gateway to the healthix portal. Functional and technical specifications the ehr interoperability team completed new hub implementation projects with six new ehr vendors: antworks, azalea, criterions, greenway-intergy, medi-ehr, and celerity. Attached are the scope documents for each of these new hub builds. These documents describe the functionality and project tasks that each new participant can expect when integrating with healthix with one of these vendors. In order to integrate with healthix, we ask each of these vendors to comply with the following technical specifications: - healthix hl7 adt v1.6 or healthix_inbound_outbound_ccd_specs_v1.6 - healthix ihe transport mechanism v1 or healthix provider flat file_specification_v16 (1) for sending and receiving clinical data in the form of a ccd/c-cda.”

“The organization's audit and compliance committee assumes responsibility for the oversight of the audit of its financial statements and selection of its independent auditors. The policy for selection and oversight of the independent auditors has not changed since last year.”